The Anavex Life Sciences Presentation title: ‘. Neuroprotective effect of activators / agonists of the sigma-1 chaperone protein toxicity against amyloid in a mouse mode ‘The authors. Are: Tanguy Maurice , Vanessa Villard , Johann Meaner , Emetine basement , Fanny malaria , Alexandre Vamvakides 1 Inserm U. Montpellier II, Montpellier, France 2 Anavex Life Sciences, Pallini, Greece.
For full prescribing information, please visit or call 877-RAPTIVA.Serono, Genentech partners outside the United States and in Japan recently announced that it received approval for Raptiva in 33 countries, including the European Union, Switzerland, Australia, Argentina, Mexico and Brazil. From 25 countrieson approval was obtained in late September recommends after a unanimous positive opinion from 25 countries, of the Committee for Medicinal Products for Human Use recommended approval. Serono announced earlier this month that Raptiva is now in 15 countries in its territories. It is awaiting the results of marketing applications in a number of other countries in the areas for which it is responsible. Continue reading